+86-152-0110-8103 yanglm@beilupharma.com
EN
Contact Us
Beilu Pharmaceuticals

Beilu Pharmaceuticals

Beilu Pharma's product portfolio focuses: 

Contrast Media, Beilu Pharma offers a comprehensive range of Contrast Media adapting to customers' needs. Aiming to provide you with high-quality imaging contrast agents we are committed to becoming one of the most professional Contrast Media manufacturers worldwide. 

Anti-diabetic drugs, Glimepiride tablets and Repaglinide tablets, used for the treatment of type 2diabetic patients. 

Traditional Chinese medicine-jiuweizhenxin Granules is used to treat neurotic diseases, such as generalized anxiety disorder, insomnia etc.

Contrast Media

The Contrast Media products of Beilu Pharma can be divided into two main categories. One is the gadolinium-based Contrast Media, which is an intravenous injection mainly used to enhance the image quality of internal organs, blood vessels and tissues during magnetic resonance imaging (MRI) examinations. The other contrast medium is the iodinated-based Contrast Media, which is the most common Contrast Media used in radiological diagnosis and interventional therapy.
Gadopentetate Dimeglumine Injection/API MRI CM

Gadopentetate Dimeglumine Injection/API

Gadobutrol Injection/API MRI CM

Gadobutrol Injection/API

Gadobenate Dimeglumine Injection MRI CM

Gadobenate Dimeglumine Injection

Ferric Ammonium Citrate Effervescent Granules MRI CM

Ferric Ammonium Citrate Effervescent Granules

Iohexol Injection CT/X-Ray

Iohexol Injection

Iopamidol Injection CT/X-Ray

Iopamidol Injection

Iodixanol Injection CT/X-Ray

Iodixanol Injection

API

An active pharmaceutical ingredient (API) is the part of any medicine that produces the desired effect. Beilu Pharma can provide different API, including Iohexol, Iopamidol, Ioversol , Iopromide, Iodixanol, etc.
Iohexol

Iohexol

Iopamidol 

Iopamidol 

Anti-Diabetic Drugs

Generic drug Glimepiride Tablets (® Dibei) was first launched by Beilu Pharma in China in 2001, which has passed the Drug Consistency Evaluation. Generic drug Repaglinide Tablets (®Ruiliean) was first launched by Beilu Pharma in China in 2011.
Glimepiride Tablets

Glimepiride Tablets

Repaglinide Tablets

Repaglinide Tablets

Anti-Anxiety Drug

Jiuweizhenxin Granules was lauched in 2008, the NMPA approved Traditional Chinese Medicine that for treatment of anxiety disorders. It has been commercialized and widely used in China because of its' obviously safer and fewer side effects .
Traditional Chinese Medicine-Jiuweizhenxin Granules

Traditional Chinese Medicine-Jiuweizhenxin Granules

What's New at Beilu
Beilu Pharma's Contrast Media Production Line Passed EU GMP Certification.
Beilu Pharma's Contrast Media Production Line Passed EU GMP Certification. Recently, Beijing Beilu Pharmaceutical Co., Ltd. received the "Certificate Of GMP Compliance Of A Manufacturer" issued by the Dutch Medicines Evaluation Board in accordance with the relevant... 2024-11-14
Beilu Pharmaceutical Obtains GMP Certification from ANVISA 2024-11-01
Hichi Pharmaceutical's Iodixanol API Approved for Market 2024-09-09
Contact Us
Welcome your presence. You can send us an email, and we will get in touch with you within 24 hours.
*
*
*
*
*
*
Contact Us
If you need knowledge or quotations about medicines , please consult us.
MRI Contrast Media
CT/X-Ray Contrast Media
Anti-Diabetic Drugs Anti-Anxiety Drug
Company Contact Us Report a Side Effect
Specialities
Beijing Beilu Pharmaceutical Co., Ltd.
Copyright © Beijing Beilu Pharmaceutical Co., Ltd. All Rights Reserved.
Sitemap Privacy Policy